Irene Mittermann

Dr. Irene Mittermann

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Methods
Verified
Journal Article
Closed access
CLChristian Lupinek
Christian Lupinek
EWEva Wollmann
Eva Wollmann
ABAlexandra Baar
Alexandra Baar
SBSrinita Banerjee
Srinita Banerjee
HBHeimo Breiteneder
Heimo Breiteneder
RVRudolf Valenta
Rudolf Valenta

1 June 2010 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
IMIrene Mittermann
Irene Mittermann
MZMihaela Zidarn
Mihaela Zidarn
MSMira Silar
Mira Silar
ZMZora Markovic-Housley
Zora Markovic-Housley
WAWerner Aberer
Werner Aberer
RVRudolf Valenta
Rudolf Valenta

1 March 2009 in Trends in Immunology
Verified
Journal Article
Closed access
RVRudolf Valenta
Rudolf Valenta
IMIrene Mittermann
Irene Mittermann
TWThomas Werfel
Thomas Werfel
HGHolger Garn
Holger Garn
HRHarald Renz
Harald Renz

26 May 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
IMIrene Mittermann
Irene Mittermann
GWGustav Wikberg
Gustav Wikberg
CJCatharina Johansson
Catharina Johansson
CLChristian Lupinek
Christian Lupinek
LLLena Lundeberg
Lena Lundeberg
ASAnnika Scheynius
Annika Scheynius
Atopic dermatitis (AD) is a complex chronic inflammatory disease where allergens can act as specific triggering factors. To characterize the specificities of IgE-reactivity in patients with AD to a broad panel of exogenous allergens including microbial and human antigens. Adult patients with AD were grouped according to the SCORAD index, into severe (n = 53) and moderate AD (n = 126). As controls 43 patients were included with seborrhoeic eczema and 97 individuals without history of allergy or skin diseases. Specific IgE reactivity was assessed in plasma using Phadiatop®, ImmunoCap™, micro-arrayed allergens, dot-blotted recombinant Malassezia sympodialis allergens, and immune-blotted microbial and human proteins. IgE reactivity was detected in 92% of patients with severe and 83% of patients with moderate AD. Sensitization to cat allergens occurred most frequently, followed by sensitization to birch pollen, grass pollen, and to the skin commensal yeast M. sympodialis. Patients with severe AD showed a significantly higher frequency of IgE reactivity to allergens like cat (rFel d 1) and house dust mite (rDer p 4 and 10), to Staphylococcus aureus, M. sympodialis, and to human antigens. In contrast, there were no significant differences in the frequencies of IgE reactivity to the grass pollen allergens rPhl p 1, 2, 5b, and 6 between the two AD groups. Furthermore the IgE reactivity profile of patients with severe AD was more spread towards several different allergen molecules as compared to patients with moderate AD. We have revealed a hitherto unknown difference regarding the molecular sensitization profile in patients with severe and moderate AD. Molecular profiling towards allergen components may provide a basis for future investigations aiming to explore the environmental, genetic and epigenetic factors which could be responsible for the different appearance and severity of disease phenotypes in AD.

1 May 2007 in Journal of Molecular Biology
Verified
Journal Article
Closed access
SPSivaraman Padavattan
Sivaraman Padavattan
TSTilman Schirmer
Tilman Schirmer
MSMargit Schmidt
Margit Schmidt
CACezmi Akdis
Cezmi Akdis
RVRudolf Valenta
Rudolf Valenta
ZMZora Markovic-Housley
Zora Markovic-Housley

1 January 1995 in Plant Molecular Biology
Verified
Journal Article
Closed access
PDF file
IMIrene Mittermann
Irene Mittermann
Ines SwobodaInes Swoboda
Ines Swoboda
EPElisabeth Pierson
Elisabeth Pierson
NENorbert Eller
Norbert Eller
DKDietrich Kraft
Dietrich Kraft
EHErwin Heberle-Bors
Erwin Heberle-Bors